HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model.

AbstractPURPOSE:
Colorectal cancer is the third most frequent cancer in industrial nations. Therapeutic strategies to treat metastatic disease and prevent recurrence are needed. Anti-tumor immunity can be induced by dendritic cells. Dendritic cells can be expanded by the fms-like tyrosine kinase 3 ligand (Flt3L) in vivo. The aim of this study was to develop an adenoviral-based immune-gene therapy of colorectal cancer with Flt3L in a BALB/c mouse model.
METHODS:
A new Flt3L-encoding adenoviral vector (pAdFlt3L) was administered in two approaches in a CT26 colon cancer model in female BALB/c mice. In the therapeutic approach, pAdFlt3L was injected into the tail vein or directly into subcutaneous CT26 colon carcinoma tumors in BALB/c mice. In the vaccination protocol, mice were vaccinated with CT26 cell lysate and pAdFlt3L subcutaneous prior to subcutaneous application of vital CT26 cells.
RESULTS:
Application of pAdFlt3L led to high levels of Flt3L in vitro and in vivo. Significant expansion of dendritic cells after application of pAdFlt3L in vivo was confirmed by the use of CD11c and CD11b surface markers in immunohistochemistry and flow cytometry (p = 0.019). In the therapeutic approach, neither intravenous nor intratumoral treatments with pAdFlt3L lead to regression of CT26 tumors. In the vaccination protocol, vaccination completely prevented tumor growth and resulted in superior survival compared to control mice (p < 0.001).
CONCLUSIONS:
Our results demonstrate that immunostimulatory therapy with pAdFlt3L is effective to prevent tumor development through vaccination and may represent a therapeutic tool to prevent metastatic disease.
AuthorsCarina Riediger, Gerhard Wingender, Percy Knolle, Sebastian Aulmann, Wolfgang Stremmel, Jens Encke
JournalJournal of cancer research and clinical oncology (J Cancer Res Clin Oncol) Vol. 139 Issue 12 Pg. 2097-110 (Dec 2013) ISSN: 1432-1335 [Electronic] Germany
PMID24114287 (Publication Type: Journal Article)
Chemical References
  • Membrane Proteins
  • flt3 ligand protein
Topics
  • Adenoviridae (genetics)
  • Animals
  • Cell Proliferation
  • Colorectal Neoplasms (immunology, pathology, prevention & control)
  • Disease Models, Animal
  • Female
  • Genetic Therapy (methods)
  • Genetic Vectors
  • HEK293 Cells
  • Humans
  • Immunotherapy
  • Membrane Proteins (genetics, immunology)
  • Mice
  • Mice, Inbred BALB C
  • Tumor Cells, Cultured
  • Vaccination
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: